In February of 2017, the U.S. Chamber of Commerce (Chamber)
released its 2017 International IP Index.
(Index). Unsurprisingly, the
overall conclusion is that IP is the medicine for all that ills countries. The 148 page Index contains a helpful
description of the purpose and function of the Index:
Now in its fifth edition, the U.S. Chamber’s International IP
Index continues to provide an important industry perspective on the IP
standards that influence both long- and short-term business and investment
decisions. The Index is a unique and continuously evolving instrument. Not only
does it assess the state of the international IP environment, it also provides
a clear roadmap for any economy that wishes to be competitive in the 21st
century knowledge-based global economy. Large, small, developing, or
developed—economies from across the world can use the insights about their own
national IP environments as well as that of their neighbors and international
competitors to improve their own performance and better compete at the highest
levels for global investment, talent, and growth.
Notably, part of the Index focuses
on the “Innovation and Creativity Life Cycle.”
In examining the life cycle, the Index notes that there is a strong
correlation between robust IP rights and “knowledge intensive jobs,” “biotechnology
innovation,” “greater access to licensed music content,” “creative outputs,” “nearly
50% more attractive to foreign direct investment,” and “online activity” to
name a few. Perhaps the most interesting
data in the Index concerns the analysis of individual countries and a breakdown
of “key strengths” and “key weaknesses” in their respective IP systems. The full Index can be found, here.
No comments:
Post a Comment